White Pine Investment Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,644
| Closed | -$406K | – | 65 |
|
|
2024
Q1 | $406K | Sell |
14,644
-13,878
| -49% | -$385K | 0.12% | 52 |
|
|
2023
Q4 | $821K | Sell |
28,522
-5,378
| -16% | -$163K | 0.27% | 49 |
|
|
2023
Q3 | $1.12M | Sell |
33,900
-5,539
| -14% | -$196K | 0.4% | 49 |
|
|
2023
Q2 | $1.45M | Sell |
39,439
-6,788
| -15% | -$264K | 0.5% | 46 |
|
|
2023
Q1 | $1.89M | Sell |
46,227
-8,765
| -16% | -$379K | 0.68% | 43 |
|
|
2022
Q4 | $2.82M | Sell |
54,992
-7,647
| -12% | -$367K | 1.07% | 39 |
|
|
2022
Q3 | $2.74M | Sell |
62,639
-12,247
| -16% | -$595K | 1.14% | 37 |
|
|
2022
Q2 | $3.93M | Sell |
74,886
-38,501
| -34% | -$1.96M | 1.55% | 30 |
|
|
2022
Q1 | $5.87M | Sell |
113,387
-6,460
| -5% | -$335K | 1.99% | 19 |
|
|
2021
Q4 | $7.08M | Sell |
119,847
-5,235
| -4% | -$259K | 2.35% | 16 |
|
|
2021
Q3 | $5.38M | Sell |
125,082
-3,395
| -3% | -$150K | 1.88% | 22 |
|
|
2021
Q2 | $5.03M | Sell |
128,477
-2,561
| -2% | -$99.6K | 1.73% | 25 |
|
|
2021
Q1 | $4.75M | Buy |
131,038
+896
| +0.7% | +$31.8K | 1.76% | 26 |
|
|
2020
Q4 | $4.79M | Sell |
130,142
-10,901
| -8% | -$400K | 1.94% | 23 |
|
|
2020
Q3 | $4.91M | Sell |
141,043
-965
| -0.7% | -$33.8K | 2.26% | 19 |
|
|
2020
Q2 | $4.41M | Sell |
142,008
-1,317
| -0.9% | -$44.7K | 2.18% | 19 |
|
|
2020
Q1 | $4.44M | Sell |
143,325
-8,074
| -5% | -$275K | 2.54% | 16 |
|
|
2019
Q4 | $5.63M | Sell |
151,399
-3,841
| -2% | -$137K | 2.31% | 20 |
|
|
2019
Q3 | $5.29M | Buy |
155,240
+2,714
| +2% | +$98.7K | 2.4% | 17 |
|
|
2019
Q2 | $6.27M | Buy |
152,526
+113
| +0.1% | +$4.49K | 2.96% | 7 |
|
|
2019
Q1 | $6.14M | Sell |
152,413
-3,332
| -2% | -$133K | 3.07% | 7 |
|
|
2018
Q4 | $6.45M | Sell |
155,745
-3,410
| -2% | -$142K | 3.45% | 4 |
|
|
2018
Q3 | $6.66M | Sell |
159,155
-511
| -0.3% | -$19.7K | 3.19% | 6 |
|
|
2018
Q2 | $5.5M | Sell |
159,666
-1,361
| -0.8% | -$46.5K | 2.85% | 9 |
|
|
2018
Q1 | $5.42M | Buy |
161,027
+1,833
| +1% | +$63K | 2.65% | 10 |
|
|
2017
Q4 | $5.47M | Sell |
159,194
-822
| -0.5% | -$28K | 2.7% | 10 |
|
|
2017
Q3 | $5.42M | Sell |
160,016
-2,846
| -2% | -$91.5K | 2.88% | 6 |
|
|
2017
Q2 | $5.19M | Sell |
162,862
-1,296
| -0.8% | -$40.9K | 2.77% | 9 |
|
|
2017
Q1 | $5.33M | Buy |
164,158
+369
| +0.2% | +$11.6K | 2.87% | 8 |
|
|
2016
Q4 | $5.05M | Sell |
163,789
-2,551
| -2% | -$77.9K | 2.73% | 11 |
|
|
2016
Q3 | $5.34M | Sell |
166,340
-2,741
| -2% | -$91.7K | 3.14% | 5 |
|
|
2016
Q2 | $5.65M | Sell |
169,081
-810
| -0.5% | -$25.9K | 3.39% | 4 |
|
|
2016
Q1 | $4.78M | Sell |
169,891
-2,024
| -1% | -$57.8K | 2.91% | 7 |
|
|
2015
Q4 | $5.26M | Sell |
171,915
-375
| -0.2% | -$11.8K | 3.24% | 5 |
|
|
2015
Q3 | $5.13M | Buy |
172,290
+191
| +0.1% | +$6.12K | 3.29% | 3 |
|
|
2015
Q2 | $5.47M | Buy |
172,099
+2,288
| +1% | +$74.6K | 3.19% | 5 |
|
|
2015
Q1 | $5.61M | Sell |
169,811
-1,054
| -0.6% | -$33.5K | 3.2% | 5 |
|
|
2014
Q4 | $5.05M | Buy |
170,865
+3,362
| +2% | +$96.4K | 2.94% | 9 |
|
|
2014
Q3 | $4.7M | Buy |
167,503
+1,687
| +1% | +$47.3K | 2.84% | 11 |
|
|
2014
Q2 | $4.67M | Buy |
165,816
+31,051
| +23% | +$885K | 2.82% | 12 |
|
|
2014
Q1 | $4.11M | Sell |
134,765
-25,265
| -16% | -$753K | 2.63% | 15 |
|
|
2013
Q4 | $4.65M | Buy |
160,030
+559
| +0.4% | +$16.3K | 3.18% | 9 |
|
|
2013
Q3 | $4.35M | Hold |
159,471
| – | – | 3.3% | 7 |
|
|
2013
Q2 | $4.24M | Buy |
+159,471
| New | +$4.41M | 3.37% | 8 |
|
Other funds holding PFE
White Pine Investment Company's PFE Position: Q2 2024 in Review
White Pine Investment Company sold out of Pfizer (PFE) in Q2 2024, closing a stake of 14,644 shares — an estimated $406K sold.
White Pine Investment Company first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $7.08M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- White Pine Investment Company reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- White Pine Investment Company sold 14,644 Pfizer shares in Q2 2024, an estimated $406K.
- White Pine Investment Company first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
- White Pine Investment Company's Pfizer position peaked at $7.08M in Q4 2021.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on White Pine Investment Company's 13F filing for Q2 2024, filed 24 Jul 2024.